药物涂层球囊治疗支架内再狭窄的未来发展方向是什么？ - Suppr | 超能文献

文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

药物涂层球囊治疗支架内再狭窄的未来发展方向是什么？ - Suppr | 超能文献

What Is the Future of Drug-Coated Balloons for In-Stent Restenosis?

作者信息

Chen Yun-Dai, Gao Lei

机构信息

Senior Department of Cardiology, the Sixth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.

出版信息

JACC Asia. 2022 Mar 1;2(2):180-181. doi: 10.1016/j.jacasi.2021.12.010. eCollection 2022 Apr.

DOI:10.1016/j.jacasi.2021.12.010

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9627812/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132d/9627812/5ad645a25568/fx1.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132d/9627812/5ad645a25568/fx1.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132d/9627812/5ad645a25568/fx1.jpg

相似文献

1

What Is the Future of Drug-Coated Balloons for In-Stent Restenosis?药物涂层球囊治疗支架内再狭窄的未来发展方向是什么？

JACC Asia. 2022 Mar 1;2(2):180-181. doi: 10.1016/j.jacasi.2021.12.010. eCollection 2022 Apr.

2

Comparison of 2 Different Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis: A Randomized Controlled Trial.两种不同紫杉醇涂层球囊治疗冠状动脉支架内再狭窄的比较：一项随机对照试验

JACC Asia. 2022 Mar 1;2(2):170-179. doi: 10.1016/j.jacasi.2021.11.015. eCollection 2022 Apr.

3

Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.紫杉醇涂层球囊导管治疗冠状动脉支架内再狭窄的长期随访。

JACC Cardiovasc Interv. 2012 Mar;5(3):323-30. doi: 10.1016/j.jcin.2012.01.008.

4

Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions.两种药物涂层球囊治疗冠状动脉支架内再狭窄病变的平行随机对照试验联合分析。

Circ Cardiovasc Interv. 2022 Sep;15(9):e012305. doi: 10.1161/CIRCINTERVENTIONS.122.012305. Epub 2022 Sep 20.

5

Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis.紫杉醇涂层球囊导管与紫杉醇涂层支架治疗冠状动脉支架内再狭窄的比较。

Circulation. 2009 Jun 16;119(23):2986-94. doi: 10.1161/CIRCULATIONAHA.108.839282. Epub 2009 Jun 1.

6

Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients.冠状动脉支架内再狭窄的治疗策略：对24项随机试验和4880例患者的系统评价与分层贝叶斯网络荟萃分析

BMJ. 2015 Nov 4;351:h5392. doi: 10.1136/bmj.h5392.

7

A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial.一种用于治疗冠状动脉支架内再狭窄的新型药物涂层刻痕球囊：多中心随机对照PATENT-C首次人体试验结果。

Catheter Cardiovasc Interv. 2016 Jul;88(1):51-9. doi: 10.1002/ccd.26216. Epub 2015 Sep 2.

8

Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon.药物涂层球囊治疗冠状动脉支架内再狭窄

JACC Cardiovasc Interv. 2019 Mar 25;12(6):558-566. doi: 10.1016/j.jcin.2018.11.040.

9

The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.LEVANT I 试验（卢特利克斯紫杉醇涂层球囊用于预防股腘动脉再狭窄）：首例人体股腘动脉血运重建的低剂量药物涂层球囊与非涂层球囊血管成形术的随机试验。

JACC Cardiovasc Interv. 2014 Jan;7(1):10-9. doi: 10.1016/j.jcin.2013.05.022.

10

Study on the safety and effectiveness of drug-coated balloons in patients with acute myocardial infarction.药物涂层球囊治疗急性心肌梗死患者的安全性和有效性研究。

J Cardiothorac Surg. 2021 Jun 21;16(1):178. doi: 10.1186/s13019-021-01525-8.

本文引用的文献

1

Comparison of 2 Different Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis: A Randomized Controlled Trial.两种不同紫杉醇涂层球囊治疗冠状动脉支架内再狭窄的比较：一项随机对照试验

JACC Asia. 2022 Mar 1;2(2):170-179. doi: 10.1016/j.jacasi.2021.11.015. eCollection 2022 Apr.

2

Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon.药物涂层球囊治疗冠状动脉支架内再狭窄

JACC Cardiovasc Interv. 2019 Mar 25;12(6):558-566. doi: 10.1016/j.jcin.2018.11.040.

3

Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial.

比较两种不同药物涂层球囊在支架内再狭窄中的疗效：RESTORE ISR China 随机试验。

JACC Cardiovasc Interv. 2018 Dec 10;11(23):2368-2377. doi: 10.1016/j.jcin.2018.09.010.

4

A novel nanocarrier sirolimus-coated balloon for coronary interventions: 12-Month data from the Nanoluté Registry.一种用于冠状动脉介入治疗的新型纳米载体西罗莫司涂层球囊：来自Nanoluté注册研究的12个月数据。

Cardiovasc Revasc Med. 2019 Mar;20(3):235-240. doi: 10.1016/j.carrev.2018.06.003. Epub 2018 Jun 28.

5

Magic Touch®: preliminary clinical evidence with a novel sirolimus drug coated balloon.Magic Touch®：一种新型西罗莫司药物涂层球囊的初步临床证据

Minerva Cardioangiol. 2018 Aug;66(4):508-517. doi: 10.23736/S0026-4725.18.04641-8. Epub 2018 Feb 19.

6

Immediate and short-term performance of a novel sirolimus-coated balloon during complex percutaneous coronary interventions. The FAtebenefratelli SIrolimus COated-balloon (FASICO) registry.新型西罗莫司涂层球囊在复杂经皮冠状动脉介入治疗中的即刻和短期性能。法特贝纳通西罗莫司涂层球囊（FASICO）注册研究。

Cardiovasc Revasc Med. 2017 Oct-Nov;18(7):487-491. doi: 10.1016/j.carrev.2017.03.025. Epub 2017 Mar 25.

7

A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial.紫杉醇涂层球囊与紫杉醇洗脱支架治疗药物洗脱支架内再狭窄的前瞻性、多中心、随机试验：来自 PEPCAD China ISR 试验的结果。

JACC Cardiovasc Interv. 2014 Feb;7(2):204-211. doi: 10.1016/j.jcin.2013.08.011.